Simpesse NDC 65862-864

NDC codes

FDA NDC Directory

Product NDC (as listed)65862-864Labeler and product segments. Claims need a package NDC.

Product NDC at billing width65862-0864Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
65862-864-95	65862086495	2 POUCH in 1 CARTON (65862-864-95) / 1 BLISTER PACK in 1 POUCH (65862-864-94) / 1 KIT in 1 BLISTER PACKMarketed from Apr 7, 2017

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Simpesse
Generic name (nonproprietary): levonorgestrel and ethinyl estradiol and ethinyl estradiol
Dosage form: Kit
Labeler: Aurobindo Pharma Limited
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 206851
Marketing start: Apr 7, 2017
Listing expires: Dec 31, 2026
Identifiers: Product ID 65862-864_bd9d6e25-de56-422b-9155-89378c5b943fSPL ID bd9d6e25-de56-422b-9155-89378c5b943fSPL set ID abea62b3-6a55-40a4-9e68-1ee9801e0f2cRxCUI 238019, 248310, 749761, 1918056

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N465862086495 followed by a unit qualifier and the quantity

Package 65862-0864-95. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 1, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

Simpesse ® (levonorgestrel and ethinyl estradiol tablets and ethinyl estradiol tablets) is indicated for use by females of reproductive potential to prevent pregnancy. Simpesse is a combination of levonorgestrel, a progestin, and ethinyl estradiol, an estrogen, indicated for use by females of reproductive potential to prevent pregnancy. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)